Eli Lilly & Co. (LLY)

1077.75 +0.77 (+0.07%) USD  |  NYSE  |  Dec 26, 16:00
1076.14 -1.61 (-0.15%) After-Hours: 20:00
More

Eli Lilly Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. --
Adverum Biotechnologies, Inc. --
Viking Therapeutics, Inc. --
Moderna, Inc. Upgrade